To investigate the pharmacokinetic effect of the medicine under physical work in healthy men MedDRA version: 16.1 Level: SOC Classification code 10022891 Term: Investigations System Organ Class: 10022891 - Investigations
Conditions
Interventions
Trade Name: Bricanyl
Pharmaceutical Form: Inhalation powder
INN or Proposed INN: Terbutaline
CAS Number: 23031-32-5
Other descriptive name: TERBUTALINE SULPHATE
Concentration unit: mg milligram(s)
Co
Sponsors
Bispebjerg Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: men age 18-40 aerobic capacity more than 50ml / min / kg more than 5h training pr week Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: smokers allergy for the medicin cronic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To investigate the pharmacokinetic effekt of the medicine under physical work and dehydration in healthy men;Secondary Objective: Not applicable;Primary end point(s): Urine concentration of salbutamol and terbutalin;Timepoint(s) of evaluation of this end point: 2 years from first participant | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): .;Timepoint(s) of evaluation of this end point: . | — |
Countries
Denmark
Contacts
Public ContactLungemedicinsk Forskningsenhed
Bispebjerg Hospital
Outcome results
None listed